lysine has been researched along with paricalcitol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutrupi, S; Mallamaci, F; Pizzini, P; Thadhani, R; Torino, C; Tripepi, G; Zoccali, C | 1 |
| Cutrupi, S; Mallamaci, F; Pizzini, P; Torino, C; Tripepi, G; Tripepi, R; Vilasi, A; Zoccali, C | 1 |
2 trial(s) available for lysine and paricalcitol
| Article | Year |
|---|---|
Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels.
Topics: Adaptor Proteins, Signal Transducing; Aged; Arginine; Biomarkers; Bone Morphogenetic Proteins; Chronic Kidney Disease-Mineral and Bone Disorder; Double-Blind Method; Ergocalciferols; Female; Fibroblast Growth Factor-23; Genetic Markers; Humans; Italy; Lysine; Male; Middle Aged; Receptors, Calcitriol; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Up-Regulation; Vitamins | 2017 |
Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients.
Topics: Aged; Arginine; Ergocalciferols; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Peroxidase; Receptor for Advanced Glycation End Products; Receptors, Calcitriol; Renal Insufficiency, Chronic; S100A12 Protein | 2017 |